SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-053575
Filing Date
2024-02-29
Accepted
2024-02-29 16:48:41
Documents
17
Period of Report
2024-02-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d786844d8k.htm   iXBRL 8-K 27869
2 EX-99.1 d786844dex991.htm EX-99.1 73675
7 GRAPHIC g786844g0228225240539.jpg GRAPHIC 4016
  Complete submission text file 0001193125-24-053575.txt   277317

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nuvb-20240229.xsd EX-101.SCH 4247
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nuvb-20240229_def.xml EX-101.DEF 13885
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nuvb-20240229_lab.xml EX-101.LAB 23296
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nuvb-20240229_pre.xml EX-101.PRE 14853
18 EXTRACTED XBRL INSTANCE DOCUMENT d786844d8k_htm.xml XML 6202
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

IRS No.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39351 | Film No.: 24704671
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)